1-20 of 118
Pallawi Torka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of patients (Pts) with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) progressing after CD3xCD20 bispecific antibody (BsAb) therapy: A new unmet need

Free
Mika Geva, Esther Drill, Clare Grieve, Michelle Okwali, Alexander Boardman, Philip Caron, Paola Ghione, Philipp Berning, Paul Hamlin, Colette Owens, Kevin David, Steven Horwitz, Anita Kumar, Ariela Noy, Alison Moskowitz, Efrat Luttwak, Lia Palomba, Zachary Epstein-Peterson, Raphael Steiner, Robert Stuver, Pallawi Torka, William Johnson, Jasmine Zain, Andrew Intlekofer, Ahmet Dogan, Santosha Vardhana, Riley Riley, DeVona Reese, Amanda Chron, Lynnette Henshaw, Jennifer Lue, Andrew Zelenetz, Gilles Salles, Lorenzo Falchi
Journal: Blood
Blood (2025) 146 (Supplement 1): 2756.
https://doi.org/10.1182/blood-2025-2756
Published: 2025
Journal Articles

Detection of intratumoral microorganisms in DLBCL impacts on CART-cell outcomes

Free
Paola Ghione, Roni Shouval, Rita Tavarozzi, Teng Fei, Magdalena Corona De Lapuerta, Sigrun Einarsdottir, Silvia Escribano Serrat, Gunjan Shah, Craig Sauter, Michael Scordo, Michelle Okwali, Annie Qiu, Marina Gomez-Llobell, Alexander Boardman, Philip Caron, Kevin David, Zachary Epstein-Peterson, Lorenzo Falchi, Paul Hamlin, Steven Horwitz, Andrew Intlekofer, William Johnson, Anita Kumar, Jennifer Lue, Efrat Luttwak, Alison Moskowitz, Ariela Noy, Colette Owens, Raphael Steiner, Robert Stuver, Pallawi Torka, Santosha Vardhana, Jasmine Zain, Andrew Zelenetz, Lia Palomba, Gilles Salles, Miguel-Angel Perales, Jonathan Peled, Megan Lim, Chad Vanderbilt
Journal: Blood
Blood (2025) 146 (Supplement 1): 5341.
https://doi.org/10.1182/blood-2025-5341
Published: 2025
Journal Articles

CXCL9 is a predictive biomarker of survival with IFNγ-targeted therapy in adult HLH patients

Free
William Johnson, Joseph Rocco, Rikita Patel, Adrianna Herskovits, Elena Mead, Jae Park, Alison Moskowitz, Zachary Epstein-Peterson, Robert Stuver, Neil Bapodra, Rabeya Molla, Andrew Intlekofer, Jennifer Lue, Lia Palomba, Ariela Noy, Jasmine Zain, Colette Owens, Lynnette Henshaw, Paola Ghione, Efrat Luttwak, Pallawi Torka, Andrew Zelenetz, Philip Caron, Anita Kumar, Lorenzo Falchi, Natasha Galasso, Paul Hamlin, Alexander Boardman, Kevin David, Raphael Steiner, Nivetha Ganesan, Tiffany Chang, Zainab Shahid, Wenbin Xiao, Annamaria Ballweg, Alina Markova, Mark Geyer, Lauren Banaszak, Roni Shouval, Sergio Giralt, Gregory Goldgof, Jodi Mones, Jeffrey Zwicker, Rekha Parameswaran, Avi Leader, Cy R. Wilkins, Simon Mantha, Jeffrey Cohen, Jessica Durkee-Shock, Matthew Sedlock, Bita Shakoory, Irini Sereti, Miguel-Angel Perales, Gilles Salles, Santosha Vardhana, Joseph Oved, Steven Horwitz
Journal: Blood
Blood (2025) 146 (Supplement 1): 2996.
https://doi.org/10.1182/blood-2025-2996
Published: 2025
Journal Articles

Real-world clinical outcomes with novel agent combination therapies for the frontline treatment of pediatric and adult advanced-stage Hodgkin lymphoma

Free
Karan Chohan, Lei Feng, Hunter Cochran, Maya Rosenberg, Leidy Isenalumhe, Elif Yilmaz, Seo-Hyun Kim, Yun Kyoung Tiger, Pallawi Torka, Hayley Flanagan, Sharon Castellino, Jonathan Bender, Radhamani Kannaiyan, Justin Kahla, B. Paige DePriest, Hiba Narvel, Samanta Catueno, Katherine Tobon, Julia Fadul, Patricia Faulkenberry, Amy Ayers, Sunita Nathan, Salmaan Mubeen, Efrat Luttwak, Jamie Flerlage, Robin Norris, Supreet Kaur, Olivia Tran, Chalothorn Wannaphut, Ashleigh Hawk, Miriam Garcia, Branko Cuglievan, Peter Riedell, Kris Mahadeo, Mehdi Hamadani, Catherine Diefenbach, Nancy Bartlett, Sairah Ahmed
Journal: Blood
Blood (2025) 146 (Supplement 1): 1852.
https://doi.org/10.1182/blood-2025-1852
Published: 2025
Journal Articles

Preliminary safety and efficacy of boven (Zanubrutinib, Obinutuzumab, and Venetoclax) as frontline therapy for older patients with Mantle Cell Lymphoma

Free
Anita Kumar, Jacob Soumerai, Reem Karmali, Jeremy Abramson, Jeffrey Barnes, Bernadette Beatty, Jason Brecher, Philip Caron, Kenneth Carson, Maria Chabowska, Madelyn Coogan, Jayne Coyle, Kevin David, Meemanage De Zoysa, Ahmet Dogan, Zachary Epstein-Peterson, Paola Ghione, Cameron Gordan, Leo Gordon, Julie Haydu, Ephraim Hochberg, Patrick Connor Johnson, Ashlee Joseph, Akshata Kakolu, Alyssa Labarre, Carissa Laudati, Jennifer Lue, Shuo Ma, Rosalba Martignetti, Colette Owens, Olivia Maas, Joanna Mi, Rachel Nazzaro, James O'Grady, Jessica Pendleton, Gilles Salles, Venkatraman Seshan, Natalie Slupe, Pallawi Torka, Andrew Zelenetz
Journal: Blood
Blood (2025) 146 (Supplement 1): 888.
https://doi.org/10.1182/blood-2025-888
Published: 2025
Journal Articles

MSK-impact heme accurately reproduces diffuse large B-cell (DLBCL) dlbclass cluster classification across clinical scenarios, including diagnosis, relapse, and histological transformation

Free
Aaron Gillmor, Alfredo Rivas-Delgado, Manik Uppal, Michelle Okwali, Menglei Zhu, Alexander Boardman, Kevin David, Zachary Epstein-Peterson, Mark Ewalt, Lorenzo Falchi, Pallavi Kanwar Galera, Paola Ghione, Paul Hamlin, Steven Horwitz, William Johnson, Anita Kumar, Jennifer Lue, Efrat Luttwak, Lia Palomba, Raphael Steiner, Robert Stuver, Pallawi Torka, Andrew Zelenetz, Allison Richards, Roni Shouval, Ahmet Dogan, Maria Arcila, Gilles Salles
Journal: Blood
Blood (2025) 146 (Supplement 1): 1766.
https://doi.org/10.1182/blood-2025-1766
Published: 2025
Journal Articles

Representation of older adults in registrational trials associated with therapeutic approvals in follicular lymphoma

Free
Ronit Juthani, Kelly Pugh, Nina Neuendorff, Pallawi Torka
Journal: Blood
Blood (2025) 146 (Supplement 1): 4410.
https://doi.org/10.1182/blood-2025-4410
Published: 2025
Journal Articles

A real-world analysis of safety and outcomes with first line nivolumab in combination with doxorubicin, vinblastine, and dacarbazine (NAVD) in patients with classic Hodgkin lymphoma (cHL) – a multicenter cohort study

Free
Allison Bock, Efrat Luttwak, Elena Nazarenko, Yizhe Xu, Swetha Thiruvengadam, Dahlia Sano, Kanithra Sekaran, John Vaughn, Daniel Reef, John Sharp, Ajay Major, Vrutti Patel, Nicole Araujo, Ritwick Mynam, Gordon Smilnak, Marisa Palmeri, Anuja Abhyankar, Drew Gerber, Ayo Falade, Praveen Ramakrishnan Geethakumari, Madiha Iqbal, Grace Baek, Mengyang Di, Boyu Hu, Urshila Durani, Hua-Jay Cherng, Alex Niu, Joanna Rhodes, Krithika Shanmugasundaram, Priyanka Pophali, Tatyana Feldman, Jakub Svoboda, Timothy Voorhees, Natalie Grover, Catherine Diefenbach, Reem Karmali, Yasmin Karimi, Alex Herrera, Pallawi Torka, Narendranath Epperla
Journal: Blood
Blood (2025) 146 (Supplement 1): 1841.
https://doi.org/10.1182/blood-2025-1841
Published: 2025
Journal Articles

Evaluation of outcomes by line of therapy in marginal zone lymphoma: Real-world evidence from 10 US academic centers

Free
Narendranath Epperla, John Sharp, Natalie Grover, Marcus Watkins, Reem Karmali, Pallawi Torka, Timothy Voorhees, Colin Thomas, Stefan Barta, Praveen Ramakrishnan Geethakumari, Nancy Bartlett, Geoffrey Shouse, Adam Olszewski
Journal: Blood
Blood (2025) 146 (Supplement 1): 4533.
https://doi.org/10.1182/blood-2025-4533
Published: 2025
Journal Articles

Insights in the management of older adults with mantle cell lymphoma amidst a changing therapeutic landscape: Lessons from a 25-year institutional experience

Free
Pallawi Torka, Ashlee Joseph, Alexander Boardman, Philip Caron, Kevin David, Zachary Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Steven Horwitz, Andrew Zelenetz, Andrew Intlekofer, William Johnson, Jennifer Lue, Efrat Luttwak, Alison Moskowitz, Ariela Noy, Colette Owens, Lia Palomba, Raphael Steiner, Robert Stuver, Santosha Vardhana, Jasmine Zain, Gilles Salles, Anita Kumar, Paul Hamlin
Journal: Blood
Blood (2025) 146 (Supplement 1): 1811.
https://doi.org/10.1182/blood-2025-1811
Published: 2025
Journal Articles

Nivolumab with doxorubicin, vinblastine, and dacarbazine (NAVD) in older adults with classic Hodgkin lymphoma: Do S1826 results hold up in the real world?

Free
Pallawi Torka, Allison Bock, Elena Nazarenko, Yizhe Xu, John Vaughn, Swetha Thiruvengadam, Ajay Major, Kanithra Sekaran, Daniel Reef, Calvin Lee, Gordon Smilnak, Efrat Luttwak, Vrutti Patel, Harsh Shah, Andrew Ip, Grace Baek, Ritwick Mynam, Dahlia Sano, Drew Gerber, Ayo Falade, Marisa Palmeri, Rudy Mrad, Madiha Iqbal, John Sharp, Timothy Voorhees, Praveen Ramakrishnan Geethakumari, Joanna Rhodes, Urshila Durani, Hua-Jay Cherng, Yasmin Karimi, Priyanka Pophali, Mengyang Di, Tatyana Feldman, Jakub Svoboda, Krithika Shanmugasundaram, Alex Niu, Natalie Grover, Reem Karmali, Alex Herrera, Catherine Diefenbach, Narendranath Epperla
Journal: Blood
Blood (2025) 146 (Supplement 1): 3622.
https://doi.org/10.1182/blood-2025-3622
Published: 2025
Journal Articles

Does increased PET avidity predict follicular lymphoma transformation? evidence from a large observational study

Free
Efrat Luttwak, Annie Qiu, Michelle Okwali, Alfredo Rivas Delgado, Alexander Boardman, Philip Caron, Lorenzo Falchi, Paola Ghione, Paul Hamlin, Steven Horwitz, Andrew Intlekofer, William Johnson, Anita Kumar, Jennifer Lue, Alison Moskowitz, Ariela Noy, Pallavi Kanwar Galera, Lia Palomba, Robert Stuver, Raphael Steiner, Pallawi Torka, Santosha Vardhana, Joachim Yahalom, Ahmet Dogan, Andrew Zelenetz, Heiko Schoder, Gilles Salles
Journal: Blood
Blood (2025) 146 (Supplement 1): 3605.
https://doi.org/10.1182/blood-2025-3605
Published: 2025
Journal Articles

A Phase II multicenter study of minimal residual disease-guided, time-limited acalabrutinib + obinutuzumab for the initial treatment of chronic lymphocytic leukemia

Free
Meghan Thompson, Anthony Mato, Lia Palomba, Lori Leslie, Andriy Derkach, David Nemirovsky, Prioty Islam, Mark Geyer, Philip Caron, Aaron Goldberg, Anita Kumar, Alison Moskowitz, Jennifer Lue, Colette Owens, Gilles Salles, Eytan Stein, Raphael Steiner, Pallawi Torka, Lori Dahncke, Emily Ordona, Mashiyate Meem, Claire Hutzler, Miranda Harris, Monica Shah, Megha Karnam, Lauren Nogan, Caitlin Maloney, Anmol Shah, Tenzin Nyima, Colleen Dorsey, Kate Doyle, Jennifer Howgate-Klingaman, Jamila Brutus, Dianna Tyznar, Anna Lincke, Rick Wray, Tatyana Feldman, Andrew Zelenetz, Lindsey Roeker
Journal: Blood
Blood (2025) 146 (Supplement 1): 5676.
https://doi.org/10.1182/blood-2025-5676
Published: 2025
Journal Articles

Epcoritamab with lenalidomide and tafasitamab in patients with relapsed/refractory diffuse large B cell lymphoma (ECLAT), a phase 2 investigator-initiated trial

Free
Pallawi Torka, Olivia Kelly, Holly Levenstein, Monifa Douglas, Helen Jacob, Regina Truong, Eleanor Eley, Susana Moscoso, Alexander Boardman, Philip Caron, Kevin David, Zachary Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Steven Horwitz, Jasmine Zain, Andrew Zelenetz, Andrew Intlekofer, William Johnson, Anita Kumar, Jennifer Lue, Efrat Luttwak, Alison Moskowitz, Ariela Noy, Colette Owens, Lia Palomba, Raphael Steiner, Robert Stuver, Santosha Vardhana, Gilles Salles, Paul Hamlin
Journal: Blood
Blood (2025) 146 (Supplement 1): 1971.
https://doi.org/10.1182/blood-2025-1971
Published: 2025
Journal Articles

Real-world outcomes of frontline polatuzumab-rchp and impact of frailty in older adults with diffuse large B-cell lymphoma

Free
Varun Iyengar, Jomel Meeko Manzano, Lu Chen, Jessica Chicola, Michelle Okwali, Seth Buller, Guido Pelaez, Vincenzo Pizzuti, Ajay Major, Youssef Youssef, Yazeed Sawalha, Danielle Wallace, Monica Masterson, Nicole Birrer, Allison Bock, Adrienne Nedved, Yucai Wang, Thomas Lucido, Joanna Rhodes, Siang Dim, Jennifer Crombie, Denisse Montana, Michele Stanchina, Juan Alderuccio, Alyssa Gibson, Peter Riedell, Tanim Jain, Benjamin Heyman, Heather Rasmussen, Chaitra Ujjani, Patrick Gould, Hua-Jay Cherng, Ahmed Bahnasy, Talal Hilal, Joseph Parker, Muhamad Alhaj Moustafa, Stacy Pak, Christine Goth, David Russler-Germain, Alex Herrera, Swetha Thiruvengadam, Pallawi Torka
Journal: Blood
Blood (2025) 146 (Supplement 1): 784.
https://doi.org/10.1182/blood-2025-784
Published: 2025
Journal Articles

Racial and ethnic disparities in the risk of second primary malignancies among diffuse large B-cell lymphoma survivors in the United States

Free
Pragati Advani, Han Yu, Kayla Catalfamo, Pallawi Torka
Journal: Blood
Blood (2025) 146 (Supplement 1): 6260.
https://doi.org/10.1182/blood-2025-6260
Published: 2025
Journal Articles

Differences in patient-reported time toxicity between bispecific antibody (BsAb) options: Impact of treatment duration and dosing frequency on patient-reported time burden in relapsed/refractory (R/R) follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL)

Free
Ajay Major, Esprit Ma, Anthony Masaquel, Mazie Tsang, Mengyang Di, Supreet Kaur, Priyanka Pophali, Sally Werner, Rebecca Bungay, Dominick Latremouille-Viau, Annie Guerin, Carolina Reyes, Mei Wu, Lourenia Cassoli, Pallawi Torka
Journal: Blood
Blood (2025) 146 (Supplement 1): 6181.
https://doi.org/10.1182/blood-2025-6181
Published: 2025
Journal Articles

Reporting of older subgroups in registration trials of FDA and EMA approvals between 2017 and 2023 for diffuse large B-cell lymphoma: A systematic review

Free
Ronit Juthani, Kelly Pugh, Colm Eochagain, Celine Soudant, Pallawi Torka, Nina Neuendorff
Journal: Blood
Blood (2025) 146 (Supplement 1): 7928.
https://doi.org/10.1182/blood-2025-7928
Published: 2025
Journal Articles

Safety and efficacy of brexucabtagene autoleucel in elderly patients with relapsed or refractory Mantle Cell Lymphoma: A retrospective, multicenter, international study

Free
Zachary Epstein-Peterson, Marina Gomez-Llobell, Vanisha Patel, Tobias Tix, Mohammad Alhomoud, Abraham Avigdor, Ofrat Beyar-Katz, Alexander Boardman, Limor Cohen, Magdalena Corona De Lapuerta, Parastoo Dahi, Sigrun Einarsdottir, Silvia Escribano Serrat, Lorenzo Falchi, Mika Geva, Andre Goy, Uri Greenbaum, Iris Halamish, Paul Hamlin, Anita Kumar, Richard Lin, Jennifer Lue, Ronit Marcus, Lia Palomba, Jae Park, Miguel-Angel Perales, Gilles Salles, Craig Sauter, Michael Scordo, Gunjan Shah, Avichai Shimoni, Roni Shouval, Marion Subklewe, Pallawi Torka, Ben Varon, Andrew Zelenetz, Kai Rejeski, Andrew Ip
Journal: Blood
Blood (2025) 146 (Supplement 1): 2710.
https://doi.org/10.1182/blood-2025-2710
Published: 2025
Journal Articles

Integrated dissociated and spatial single-cell profiling reveals that HDAC inhibition restores anti-PD-1 sensitivity in Hodgkin lymphoma by disrupting monocyte-Hodgkin-reed-sternberg cell-driven immunosuppressive niches.

Free
Amira Marouf, Sneha Mitra, Robert Stuver, Nivetha Ganesan, Jahan Rahman, Alexander Boardman, Philip Caron, Tiffany Chang, Kevin David, Zachary Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Paul Hamlin, Francisco Hernandez-Ilizaliturri, Steven Horwitz, Andrew Intlekofer, William Johnson, Reem Karmali, Jennifer Lue, Anita Kumar, Efrat Luttwak, Neena Mahajan, Ariela Noy, Colette Owens, Lia Palomba, Heiko Schoder, David Sermer, Venkatraman Seshan, Raphael Steiner, Pallawi Torka, Andrew Zelenetz, Gottfried von Keudell, Gilles Salles, Christina Leslie, Alison Moskowitz, Santosha Vardhana
Journal: Blood
Blood (2025) 146 (Supplement 1): 150.
https://doi.org/10.1182/blood-2025-150
Published: 2025